⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DAWN News
Day One Biopharmaceuticals, Inc. Common Stock
Promising Phase 1 Data for Servier's Emiltatug Ledadotin (Emi-Le) in Adenoid Cystic Carcinoma (ACC) Presented at ASCO 2026
prnewswire.com
DAWN
Form 8-K
sec.gov
DAWN
Servier finalise l'acquisition de Day One Biopharmaceuticals USA - Français USA - English USA - English
prnewswire.com
DAWN
Servier completes the acquisition of Day One Biopharmaceuticals USA - English USA - English USA - Français
prnewswire.com
DAWN
Servier completes the acquisition of Day One Biopharmaceuticals USA - English USA - Français USA - English
prnewswire.com
DAWN
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders?
prnewswire.com
DAWN
RLYB
WSR
TERN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN)
globenewswire.com
TERN
WSR
RLYB
DAWN
MRK
ARES
Are SEM, DAWN, VRE Obtaining Fair Deals for their Shareholders?
prnewswire.com
VRE
DAWN
SEM
Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN
businesswire.com
DAWN
Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care
prnewswire.com
DAWN
TCRX
ENGN
ONCY
GILD